{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:25:06Z","timestamp":1793496306030,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jdiacomp.2024.108834","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:02:16Z","timestamp":1724371336000},"page":"108834","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["The efficacy and safety of GLP-1 agonists in PCOS women living with obesity in promoting weight loss and hormonal regulation: A meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7345-0751","authenticated-orcid":false,"given":"Beatriz","family":"Austreg\u00e9silo de Athayde De Hollanda Morais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7974-0068","authenticated-orcid":false,"given":"Vit\u00f3ria","family":"Martins Priz\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4506-0472","authenticated-orcid":false,"given":"Mariana","family":"de Moura de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0788-130X","authenticated-orcid":false,"given":"Beatriz","family":"Ximenes Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0524-5616","authenticated-orcid":false,"given":"Maria Luiza","family":"Rodrigues Defante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2237-2799","authenticated-orcid":false,"given":"Otavio","family":"Cosendey Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriane Maria","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2024.108834_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CLEP.S37559","article-title":"Epidemiology, diagnosis, and management of polycystic ovary syndrome","volume":"6","author":"Sirmans","year":"2013","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0010","doi-asserted-by":"crossref","first-page":"40","DOI":"10.18544\/PEDM-24.01.0101","article-title":"Polycystic ovary syndrome (PCOS) and the accompanying disorders of glucose homeostasis among girls at the time of puberty","volume":"24","author":"Otto-Buczkowska","year":"2018","journal-title":"Pediatr Endocrinol Diabetes Metab"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0015","doi-asserted-by":"crossref","unstructured":"Rotterdam ESHRE. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod, 19(1), 41\u201347. doi:https:\/\/doi.org\/10.1093\/humrep\/deh098.","DOI":"10.1093\/humrep\/deh098"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0020","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1210\/clinem\/dgaa337","article-title":"Women with PCOS","volume":"105","author":"Xing","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0025","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/humrep\/des463","article-title":"Women with polycystic ovary syndrome have intrinsic insulin resistance on the euglycaemic-hyperinsulaemic clamp","volume":"28","author":"Stepto","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0030","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/humrep\/dew243","article-title":"Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies","volume":"31","author":"Cassar","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0035","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0040","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.rbmo.2019.04.017","article-title":"GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis","volume":"39","author":"Han","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0045","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/cen.13477","article-title":"The association between metabolic syndrome and polycystic ovary syndrome: a systematic review and meta-analysis","volume":"88","author":"Otaghi","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0050","doi-asserted-by":"crossref","first-page":"e2695","DOI":"10.1210\/clinem\/dgaa285","article-title":"Obesity, polycystic ovary syndrome, and infertility: a new avenue for GLP-1 receptor agonists","volume":"105","author":"Cena","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0055","author":"JPT"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guide- line for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0065","article-title":"RoB 2: a revised tool for assessing the risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0070","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1530\/EC-17-0327","article-title":"Effect of Liraglutide on atrial natriuretic peptide, adrenomedullin, and Copeptin in PCOS","volume":"7","author":"Fr\u00f8ssing","year":"2018","journal-title":"Endocr Connect"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0080","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.fertnstert.2022.04.027","article-title":"Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study","volume":"118","author":"Elkind-Hirsch","year":"2022","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108935","article-title":"Semaglutide reduces fat accumulation in the tongue: a randomized single-blind, pilot study","volume":"178","author":"Jensterle","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0090","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/dom.14944","article-title":"Semaglutide delays 4-hour gastric emptying in women with polycystic ovary syndrome and obesity","volume":"25","author":"Jensterle","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0095","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1080\/17512433.2021.1933433","article-title":"Update on the effects of GLP-1 receptor agonists for the treat- ment of polycystic ovary syndrome","volume":"14","author":"Siamashvili","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0100","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1517\/14656566.2014.965678","article-title":"Therapies for inter-relating diabetes and obesity \u2013 GLP-1 and obesity","volume":"15","author":"Iepsen","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0105","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.2147\/DDDT.S58459","article-title":"Liraglutide and obesity: a review of the data so far","volume":"9","author":"Ladenheim","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0110","doi-asserted-by":"crossref","first-page":"E908","DOI":"10.1210\/jc.2013-3350","article-title":"Disruption of GIP\/GIPR axis in human adipose tissue is linked to obesity and insulin resistance","volume":"99","author":"Ceperuelo-Mallafr\u00e9","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0115","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.jdiacomp.2016.07.020","article-title":"Exenatide treatment increases serum irisin levels in patients with obesity and newly diagnosed type 2 diabetes","volume":"30","author":"Liu","year":"2016","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0120","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1111\/dom.13761","article-title":"Effect of liraglutide on estimates of lipolysis and lipid oxidation in obese patients with stable coronary artery disease and newly diagnosed type 2 diabetes: a randomized trial","volume":"21","author":"Anholm","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0125","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/dom.13487","article-title":"Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: a single-centre randomized controlled study","volume":"21","author":"Matikainen","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0130","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1161\/ATVBAHA.112.246207","article-title":"Exenatide, a glucagon-like peptide-1 receptor agonist, acutely inhibits intestinal lipoprotein production in healthy humans","volume":"32","author":"Xiao","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0135","doi-asserted-by":"crossref","DOI":"10.1007\/s11906-016-0683-0","article-title":"Management of dyslipidemia in patients with hyper- tension, diabetes, and metabolic syndrome","volume":"18","author":"Srikanth","year":"2016","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0140","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of metabolic syndrome","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0145","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/cen.13477","article-title":"The association between metabolic syndrome and polycystic ovary syndrome: a systematic review and meta-analysis","volume":"88","author":"Otaghi","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0150","series-title":"Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies","article-title":"Insulin sensitizers for improving the endocrine and metabolic profile in overweight","author":"Barber","year":"2019"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007506.pub4","article-title":"Lifestyle changes in women with polycystic ovary syndrome","author":"Lim","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0160","doi-asserted-by":"crossref","first-page":"g2646","DOI":"10.1136\/bmj.g2646","article-title":"Long-term maintenance of weight loss with non-surgical interventions in obese adults: systematic review and meta-analyses of randomised controlled trials","volume":"348","author":"Dombrowski","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0165","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jama.2015.9676","article-title":"Efficacy of liraglutide for weight loss among patients with type 2 diabetes","volume":"314","author":"Davies","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0170","article-title":"Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial","volume":"1\u20139","author":"Ryan","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0175","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.3390\/ijms23084110","article-title":"Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation, and hyperandrogenism","volume":"23","author":"Armanini","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jdiacomp.2024.108834_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/pm.2020.95293","article-title":"Elevated and diagnostic androgens of polycystic ovary syndrome","volume":"19","author":"Abdelazim","year":"2020","journal-title":"Menopausal Review"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872724001600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872724001600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T23:42:29Z","timestamp":1726357349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872724001600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1056872724001600"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2024.108834","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy and safety of GLP-1 agonists in PCOS women living with obesity in promoting weight loss and hormonal regulation: A meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2024.108834","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108834"}}